Weight loss for Trulicity is typically more modest than Ozempic
Conclusion While GLP-1 agonists may help some people with inflammatory arthritis due to weight loss and better blood sugar control, the lack of strong evidence means they shouldnt replace traditional treatments
The research was supported by grants from the National Cancer Institute (CA106176, CA138833, CA095103, CA068485) and the National Institute of Diabetes and Digestive and Kidney Diseases (DK058404) of the National Institutes of Health.
Susan Akin, a 41-year-old patient at Caron Treatment Centers in Florida, began receiving Zepbound, another GLP-1 medication, for cocaine and alcohol addiction earlier this year
With obesity rates spiraling across the globe, encouraging our bodies to burn fat as a source of fuel is an increasingly important consideration